Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Real-world evidence demonstrated the long-term performance and positive...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy.
The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...
CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary BrainComputer Interface (BCI) system, the Brain Interchange,...
Atraverse Medical announced new clinical and preclinical data supporting its Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device. It...
Artivion has debuted long-term clinical data on two of its cardiac stent products, revealing each’s solution’s potential to offer extended benefits to patients.
This includes...
Biotronik announced the successful first-in-human implantations of its LivIQ leadless pacemaker system.
The implants came in Australia as part of the company’s BIO|CONCEPT.LivIQ study, a...